Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 254

1.

Lung endothelium targeting for pulmonary embolism thrombolysis.

Ding BS, Zhou YJ, Chen XY, Zhang J, Zhang PX, Sun ZY, Tan XY, Liu JN.

Circulation. 2003 Dec 9;108(23):2892-8. Epub 2003 Nov 10.

PMID:
14610017
[PubMed - indexed for MEDLINE]
Free Article
2.

P-selectin-targeting of the fibrin selective thrombolytic Desmodus rotundus salivary plasminogen activator alpha1.

Dong N, Da Cunha V, Citkowicz A, Wu F, Vincelette J, Larsen B, Wang YX, Ruan C, Dole WP, Morser J, Wu Q, Pan J.

Thromb Haemost. 2004 Nov;92(5):956-65.

PMID:
15543321
[PubMed - indexed for MEDLINE]
3.

Chemical conjugation of urokinase to magnetic nanoparticles for targeted thrombolysis.

Bi F, Zhang J, Su Y, Tang YC, Liu JN.

Biomaterials. 2009 Oct;30(28):5125-30. doi: 10.1016/j.biomaterials.2009.06.006. Epub 2009 Jun 27.

PMID:
19560812
[PubMed - indexed for MEDLINE]
4.

Experimental pulmonary embolus in the rat: a new in vivo model to test thrombolytic drugs.

Clozel JP, Holvoet P, Tschopp T.

J Cardiovasc Pharmacol. 1988;12(5):520-5.

PMID:
2468050
[PubMed - indexed for MEDLINE]
5.

Pharmacokinetic and thrombolytic properties of chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody fused to single-chain urokinase.

Holvoet P, Laroche Y, Stassen JM, Lijnen HR, Van Hoef B, De Cock F, Van Houtven A, Gansemans Y, Matthyssens G, Collen D.

Blood. 1993 Feb 1;81(3):696-703.

PMID:
8427962
[PubMed - indexed for MEDLINE]
Free Article
6.

Low-dose urokinase in massive pulmonary embolism when standard thrombolysis is contraindicated.

Bulpa P, Carbutti G, Osselaer JC, Lawson G, Dive A, Evrard P.

Chest. 2009 Oct;136(4):1141-3. doi: 10.1378/chest.08-2583.

PMID:
19809056
[PubMed - indexed for MEDLINE]
7.

[Complications of thrombolytic therapy in pulmonary embolism].

Meneveau N, Vuillemenot A, Bassand JP.

Arch Mal Coeur Vaiss. 1995 Nov;88(11 Suppl):1769-76. Review. French.

PMID:
8815838
[PubMed - indexed for MEDLINE]
8.

Massive pulmonary embolism: short-term effects of thrombolytic treatment.

Grau E, Fontcuberta J, Pagés MA, Martinez R, Félez J, Net A, Rutllant ML.

Angiology. 1986 Nov;37(11):832-9.

PMID:
3789463
[PubMed - indexed for MEDLINE]
9.

[Changes of blood coagulative and fibrinolytic system and function of pulmonary vascular endothelium after therapy in patients with acute pulmonary thromboembolism].

Pang BS, Wang C, Lu Y, Yang YH, Xing GH, Mao YL, Huang XX, Zhai ZG.

Zhonghua Yi Xue Za Zhi. 2007 Nov 20;87(43):3074-8. Chinese.

PMID:
18261355
[PubMed - indexed for MEDLINE]
10.

Targeting of antibody-conjugated plasminogen activators to the pulmonary vasculature.

Muzykantov VR, Barnathan ES, Atochina EN, Kuo A, Danilov SM, Fisher AB.

J Pharmacol Exp Ther. 1996 Nov;279(2):1026-34.

PMID:
8930213
[PubMed - indexed for MEDLINE]
11.

[Thrombolysis of rabbit's pulmonary embolism with thrombus-targeted urokinase immune liposome].

Lü CP, Yang H, Wang J, Dong XL.

Zhonghua Xin Xue Guan Bing Za Zhi. 2009 Nov;37(11):1035-8. Chinese.

PMID:
20137334
[PubMed - indexed for MEDLINE]
12.

A recombinant antibody-targeted plasminogen activator with high affinity for activated platelets increases thrombolytic potency in vitro and in vivo.

Wan H, Liu Z, Xia X, Gu J, Wang B, Liu X, Zhu M, Li P, Ruan C.

Thromb Res. 2000 Feb 1;97(3):133-41.

PMID:
10680644
[PubMed - indexed for MEDLINE]
13.

Principles of thrombolysis in pulmonary embolism.

Prewitt RM.

Chest. 1991 Apr;99(4 Suppl):157S-164S. Review.

PMID:
2009813
[PubMed - indexed for MEDLINE]
14.

Thrombolytic therapy with urokinase for pulmonary embolism in patients with stable hemodynamics.

Zhang Y, Sun T, He B, Wang L.

Med Sci Monit. 2007 Jan;13(1):CR20-3. Epub 2006 Dec 18.

PMID:
17179905
[PubMed - indexed for MEDLINE]
15.

Local inhibition of thrombosis using urokinase linked to a monoclonal antibody which recognises damaged endothelium.

de Bono DP, Pringle S.

Thromb Res. 1991 Mar;61(5-6):537-45.

PMID:
2028455
[PubMed - indexed for MEDLINE]
16.

Efficacy of thrombolytic therapy in pulmonary embolism determined by MION-enhanced MRA: an experimental study in rabbits.

Frank H, Loewe R, Loewe C, Oberhuber G, Schwaighofer B, Huber K, Weissleder R.

Invest Radiol. 1998 Dec;33(12):853-7.

PMID:
9851818
[PubMed - indexed for MEDLINE]
17.

Thrombolytic therapy for postoperative pulmonary embolism.

Molina JE, Hunter DW, Yedlicka JW, Cerra FB.

Am J Surg. 1992 Apr;163(4):375-80; discussion 380-1.

PMID:
1558278
[PubMed - indexed for MEDLINE]
18.

Value of transthoracic echocardiography in therapy regimens evaluation in pulmonary embolism.

Zhu L, Wang C, Yang Y, Wu Y, Zhai Z, Dai H, Pang B, Tong Z.

J Thromb Thrombolysis. 2008 Dec;26(3):251-6. Epub 2007 Aug 21.

PMID:
17705052
[PubMed - indexed for MEDLINE]
19.

A novel method to isolate and map endothelial membrane proteins from pulmonary vasculature.

Zhou YJ, Wang SQ, Zhang J, Zhang W, Bi F, Guo ZG, Ding BS, Kumar P, Liu JN, Tan XY.

Am J Physiol Cell Physiol. 2005 Apr;288(4):C950-6. Epub 2004 Dec 8.

PMID:
15590900
[PubMed - indexed for MEDLINE]
Free Article
20.

Successful treatment of massive pulmonary embolism with prolonged catheter-directed thrombolysis.

Kelly P, Carroll N, Grant C, Barrett C, Kocka V.

Heart Vessels. 2006 Mar;21(2):124-6.

PMID:
16550314
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk